This announcement is a separate document:
诺诚健华:上海市方达律师事务所关于诺诚健华医药有限公司(InnoCare Pharma Limited)2024年第一次临时股东大会(股东特别大会)的法律意见书
Nuocheng Jianhua: Legal Opinion of Shanghai Fangda Law Firm on the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of InnoCare Pharma Limited (InnoCare Pharma Limited)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.